Chronic hepatitis B virus (HBV) infection is known to be one of the major causes in the development of hepatocellular carcinoma (HCC), although the biomolecular mechanism(s) involved remain unclear. To identify the cellular gene(s) involved in HBV-associated hepatocarcinogenesis, we used the mRNA dierential display method and examined three paired tumor and nontumor tissues, all of which had chromosomally integrated HBV-DNA through chronic infection. Using 240 dierent combinations of three one-base anchored oligo-dT primers and 80 arbitrary 13-mers, genes decreased or increased in expression more than twofold between each tumor tissue and its paired nontumor tissue were identi®ed. Twenty-nine known genes and four novel genes were dierentially over-expressed in the HCC tumor tissues. In contrast, 27 known genes and ®ve novel genes were under-expressed in those tumor tissues. The nucleotide sequences of the nine novel gene fragments were determined and their expression patterns were examined in 40 HCC samples. HA61T2, PT18, HG63T1, and HG57T1 were preferentially over-expressed in 32 cases (80%, P50.001), 24 cases (60%), 23 cases (57.5%) and 22 cases (55%) of the 40 tumor tissues, respectively. There was an increased frequency of HG57T1 over-expression in HCC patients with HBVpositive serology and low serum alpha-feto protein (AFP) levels (P50.05). DNT10, PT8, PT19, ENT25 and HA6T4 were under-expressed in 26 cases (65%), 23 cases (57.5%), 21 cases (53%), 20 cases (50%) and 18 cases (45%) of the 40 tumor samples, respectively. There was a strong correlation of DNT10 under-expression with high serum AFP level in HCC patients, irrespective of HBV serology (P50.01). HA6T4 was preferentially under-expressed in HCC tumors in patients with HBVpositive serology and high serum AFP levels (P50.05). Thus, the functional analyses of the known and novel genes identi®ed in this study should prove valuable to further understand the mechanism(s) of hepatocarcinogenesis. Oncogene (2001) 20, 4568 ± 4575.
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Keywords: HCC; HBV; genes; DD ± PCR; hepatocarcinogenesis Chromosomally integrated hepatitis B virus (HBV) ± DNA is detectable in over 90% of HBV surface antigen (HBsAg)-positive hepatocellular carcinomas (HCC) (Koshy et al., 1981) , and this molecular ®nding is considered to be of crucial importance in the development of HCC. Unlike the woodchuck model, in which speci®c HBV ± DNA integration occurs preferentially in c-myc or in N-myc regulatory or coding sequences (Buendia, 1992) , speci®c HBV insertion into cellular genes has been found to be a rare event in humans. DNA integration sites are random and such integration occurs at random times during the course of chronic viral infection (Lugassy et al., 1987; Chen et al., 1989) . Thus, the rearrangement of viral sequences following integration into human DNA appears not to be a speci®c marker for HCC, since non-neoplastic hepatocytes may have similar patterns of integration. The recent discovery of transactivating functions exerted by HBV X protein (HBx) (Twu and Schoemer, 1987; Spandau and Lee, 1988) and truncated middle HBs (MHBs t ) Kekule et al., 1990) proteins provide an alternative mechanism for HBV-associated hepatocellular carcinogenesis. These ®ndings have generally been derived from in vitro experiments and their biological contributions to hepatocarcinogenesis in vivo need to be further elucidated.
Because cancer is a genetic disease, it is important to understand what genes are involved and how they work. One approach to understanding how genetic and molecular changes lead to cancer development is to compare gene expression in tumor and nontumor tissues. Several methodologies, such as expressed sequence tag analysis (Adams et al., 1993) , dierential or subtractive hybridization cDNA screening (Rothstein et al., 1993) , dierential display (DD)-PCR (Liang and Pardee, 1992) , subtractive hybridization PCR (Timblin et al., 1990) and cDNA microarrays (DeRisi et al., 1996) ; have been developed to identify mRNAs that are dierentially expressed between tumor and nontumor tissues. The DD ± PCR method identi®es dierentially expressed mRNAs based on their ability to hybridize with speci®c primer sequences. Using only small amounts of RNA, this technique can identify increased or decreased mRNA levels simultaneously and relatively rapidly. Previously, CD24 and aldolase reductase family protein genes were successfully identi®ed as an HCC biomarker gene and genes involved in hepatocarcinogenesis, respectively, by the DD ± PCR cloning method (Huang and Hsu, 1995; Scuric et al., 1998) . However, other genes involved in the multistage HCC process remain to be identi®ed. We chose three HBV-associated HCC tissues at dierent clinical stages of chronic HBV infection. Two of them (patients A and C) are indicative of the integrated stage of chronic HBV infection in which HBx and MHBs are expressed, while the third (patient B) is in the replicated stage without expression of HBx and MHBs.
Three patients were selected and tested for HBV and for HCV markers in their sera using a Cobra Core EIA kit (F Homann-La Roche Ltd., Basel, Switzerland). HBV-DNA was quantitated by a liquid hybridization assay (Abbott Laboratories, North Chicago, IL, USA) with a detection limit of 1.7 pg/ml. The level of AFP was quantitatively determined by a Microparticle Enzyme Immunoassay (Abbott). Patients A and C were positive for HBsAg and HBV e antibody (HBeAb), and were negative for HBs, HBV e antigen (HBeAg), HBV ± DNA, and hepatitis C virus (HCV) antibodies. Patient B was positive for HBsAg, HBeAg, and HBV ± DNA (720 pg/ml), but was negative for HBsAb, HBeAb, and HCVAb. These results are indicative of the integrated stage of HBV in patients A and C and of the replicated stage of HBV in patient B. Patient A had a normal range of serum alpha-feto protein (AFP) (7 ng/ml) while patients B and C had high serum levels of AFP (1750 and 10 580 ng/ml, respectively). In patient A, the histology of the tumor tissue showed an Edmonson grade II/IV HCC and mild periportal in¯ammation, focal or unicellular necrosis, and minimal portal ®brosis. Patient B revealed an Edmonson grade II HCC and severe periportal and portal in¯ammation, bridging necrosis, and septal ®brosis with architectural distortion and no obvious cirrhosis. Patient C showed an Edmonson grade III HCC and mild portal in¯ammation without evidence of ®brosis. The liver disease of each patient was rated according to the histology activity index (HAI) as previously described (Scheuer, 1991) . Sections were treated with 0.3% hydrogen peroxide for 3 min and with blocking antibody for 30 min. The sections were incubated with primary antibody, including those recognizing HBs, HBc, or AFP (Novocastra Laboratories, Newcastle, UK), or HBx (Dr Y-D Yoon, MokAm Research Institute, Suwon, Korea), diluted 1 : 100 to 1 : 1000 in 1 M Tris-buer (pH 7.5) for 1 h. Detection was performed using the avidin-biotinperoxidase complex method and 3,3'-diaminobenzidine was used as the chromogen. Counter-staining was performed with Meyer's hematoxylin. Tumors were evaluated for the percentage of positive cells and the intensity of staining. Negative controls included samples incubated with PBS, or with mouse IgG 1 instead of the primary antibody. The tumor tissues of patients A and C were positive for cytoplasmic HBsAg and HBxAg, and minor parts of nontumor tissues adjacent to the tumor tissues were also positive for Figure 1 Chromosomal integration of HBV DNA and expression of HBV protein mRNAs. (a) Southern blot analysis of HCC (T) DNA in patients A, B and C. Nontumor tissue (N) DNAs were in lanes 1, 3, and 5, respectively. Tumor tissue DNAs were in lanes 2, 4, and 6, respectively. Ten mg aliquots of genomic DNA were digested with BamHI, electrophoresed on 1% agarose gels, and transferred onto nylon membranes in 0.4 N NaOH and hybridized with 32 P-labeled HBx DNA (subtype adr 4) in hybridization buer at 658C overnight. The membranes were then washed in 26SSC (150 mM NaCl, 15 mM sodium citrate), 0.1% sodium dodecyl sulphate (SDS) at 658C for 20 min twice, then washed in 0.26SSC, 0.1% SDS at 658C for 20 min. (b) The expression of HBx and Middle HBs mRNAs on Northern blot. Aliquots of 20 mg nontumor (N) and tumor (T) total RNAs were fractionated on 1% agrose gels containing 2.2% formaldehyde and 50 mM 3-[N-morpholino]propanesulphonic acid (MOPS), and were transferred to a nylon membrane. The membrane was crosslinked using a UV cross-linker (Stratagen, La Jolla, CA, USA) and was individually hybridized with each cDNA probe generated from a digested cDNA insert labeled with a-32 P-dCTP (3000 Ci/ mmol; NEN Life Science Products, Boston, MA, USA) by random priming. Hybridization and washing conditions were the same as described previously (Kim et al., 1999) , and the blots were then exposed to X-ray ®lm at 7708C. The blots were individually hybridized with each cDNA probe, middle HBs (pre S2 and S) or HBx, generated from a digested cDNA insert labeled with a-32 P-dCTP. Hybridization and washing conditions were the same as described in Southern blot analysis, and blots were then exposed to X-ray ®lm at 7708C. The cDNA probe for HBx was a generous gift from Dr Y-D Yoon and the cDNA probe for middle HBs (pre S2 and S) was a gift from Dr B-K Chae (Keimyung University, Taegu, Korea) To observe HBV ± DNA integration into genomic DNA in all three patients we used an internal fragment of HBV (HBx cDNA) as a probe and compared the HBV ± DNA patterns between the tumor and nontumor tissues by Southern blot analysis (Figure 1a) . Digested HBV-DNA patterns were observed in tumor and in nontumor tissues in patients A and B. However, the integration of HBV ± DNA was observed in tumor tissue, but not in nontumor tissue in patient C. Northern blot analysis revealed that HBx and middle HBs mRNAs were expressed in the HCC tumor tissues, but not in the nontumor tissues of patients A and C (Figure 1b ), who were in the integrated stage of chronic HBV infection (low HBV ± DNA and positive HBeAb). In contrast, neither HBx nor middle HBs was expressed in the HCC tumor tissue of patient B; low levels of HBx and middle HBs mRNAs were detected in the nontumor tissue, which was consistent with the replicated stage of chronic HBV infection (high HBV ± DNA and positive HBeAg) in that patient.
The DD ± PCR method was used to identify genes dierentially expressed in human HCC tissues compared with matched nontumor tissues. Approximately 80 bands per reaction were generated, and thus over 40 000 transcripts from DD ± PCR gels were obtained from each sample, using 240 dierent combinations of three one-base anchored oligo-dT primers and 80 arbitrary 13-mers. About 400 dierential display cDNA patterns between tumor and nontumor liver tissues were obtained and were then cloned into the TA vector. The sequenced cDNAs were analysed via the BLAST program for matches in the GeneBank database and were compared with each other via FASTA analysis. All cDNA clones were subjected to Northern blot analysis using the total RNA from the original tissue to select correct clones. Hybridized signals by Northern blotting were then calculated as fold induction comparing nontumor to HCC tissues, or vice versa. The genes decreased or increased in expression more than twofold between each tumor tissue and its paired nontumor tissue were identi®ed. Thirty-three kinds of cDNA clones were dierentially expressed in tumor tissues and 31 kinds were dierentially expressed in nontumor tissues (Table 1) . CPS I (Lawson et al., 1975) and PSTI (Murata et al., 1988; Ohmachi et al., 1993) genes are HCC-related, as previously reported. Both H19 and IGF II oncofetal RNAs were up-regulated in HCC tissue versus nontumor tissue. H19 and IGF II genes are tightly linked on human chromosome 11p15.5 and have been demonstrated to be necessary for embryonal development in humans (Zemel et al., 1992) . Both genes are reciprocally imprinted, with expression of the maternal H19 and paternal IGF II alleles, and are normally characterized by monoallelic expression. Recently, loss of imprinting (LOI) which produces biallelic expression has been observed in HCC (Sohda et al., 1998) and other tumors (Wake et al., 1998; Ross et al., 1999) . This LOI of IGF II in HCC was not linked to downregulation of H19 expression, but was rather associated with the co-expression of H19 and IGF II (Kim and Lee, 1997) . Glutamine synthetase mRNA (HA65T1) has been well known to be more highly expressed in HCC tumor versus nontumor tissues (Matsuno and Goto, 1992; Laurence et al., 1994) . In addition, 13 ribosomal protein genes (acidic ribosomal phosphoprotein P0, S20, L27a, L8, L31, L37a, S24, S27a, L21, L35a, S8, L37a, and S3a), and four mitochondrial genes (ND3, ND1, ATPase 6/8, and cytochrome b) were up-regulated in the HCC tissues (Table 1A) . The human acidic ribosomal phosphoprotein P0 was preferentially expressed in HCC as previously reported (Barnard et al., 1992; . In contrast, hepatic aldolase, a member of the glycolytic enzyme family, is highly expressed in normal liver and in hypoxic liver (Wenger et al., 1995) , and was preferentially expressed in nontumor tissue (483-fold). NNMT catalyzes the N-methylation of nicotinamide and other pyridines and is regulated by a genetic polymorphism (Aksoy et al., 1994) . Recently, NNMT has been reported as a marker of cancer cachexia in mice bearing colon 26 adenocarcinoma (Okamura et al., 1998) . Our study showed that diseased nontumor liver was the origin of the NNMT. Thus, it remains necessary to examine serum NNMT activity and to clarify its role in patients with HCC. Intriguingly, the Rb gene was preferentially expressed in nontumor tissue adjacent to HCC that was negative for HBV protein expression. Inactivation of the Rb gene is considered to play a fundamental role in the genesis and progression of several human cancers including HCC. Moreover, analysis of Rb status at the protein level was reported to be more sensitive than the actual mutational analysis . A variety of acute phase protein genes, including serum amyloid A protein, C-reactive protein, alpha-1 acid glycoprotein, prealbumin (transthyretin), albumin, hemopexin, retinol binding protein 4 and ®brinogen alpha chain, and oxidation-associated genes including metallothionein genes were highly expressed in nontumor tissue. Acute-phase reactants are usually present at high concentrations in the sera of patients with liver disease, and moreover, they rise dramatically after HCC resection (Trautwein et al., 1996; Hu et al., 1999) . However, the origin of these high concentrations is not completely understood, and whether HCC tissue is a contributing factor is controversial. Our results indicate that these acute-phase reactants are released from nontumor tissue. Genes involved in hemostasis or lipid metabolism, including coagulation factor IX and Figure 2 The nucleotide sequences and mRNA expressions of nine novel genes isolated by the DD-PCR method. (a) The nucleotide sequences of nine novel genes, HA61T2, PT18, HG63T1, HG57T1, DNT10, PT8, PT19, ENT25 and HA6T4, were completely determined. Sequence analysis was performed in both directions using T7 and SP6 primers with a¯uorescent automated DNA sequencer. The sequenced cDNAs were analysed via the BLAST program for matches in the GeneBank database and compared with each other via FASTA analysis. Modi®ed DD ± PCR was performed using a GeneHunter RNA image kit (GeneHunter Corp, Nashville, TN, USA). Based on an improved method as previously described (Liang et al., 1994) , 4 mg of total RNA from tumor or nontumor tissues were reverse-transcribed with 200 U SuperScript II RT enzyme (Gibco ± BRL, Grand Island, NY, USA) in the presence of 1 mmol/l one-base anchored oligo(dT) primers for 1 h at 428C in a total volume of 10 ml. The reaction was terminated by incubation at 758C for 10 min. Two ml of each reaction mixture was PCR ampli®ed with Dynazyme (Finnzyme OY, Epsoo, Finland) in 1 mmol/L H-AP, a 13-mer (5' end primers) and oligo(dT) 15 primers (3' end primers), using a GeneAmp PCR system 9600 (Perkin Elmer, Norwalk, CT, USA). Two hundred and forty PCR reactions were carried out on each sample. The cycling conditions were as follows: 948C for 30 s, 428C for 1 min, 728C for 30 s for 40 cycles followed by an extension at 728C for 5 min. Each PCR reaction was stopped by the addition of stop solution and was heated at 948C for 2 min and displayed on a denaturing 6% polyacrylamide gel. To avoid the possibility of losing rarer mRNAs and to minimize errors in the PCR procedure that would generate spurious bands, duplicate samples were analysed with dierent amounts of RNA. The polyacrylamide gel was blotted on a piece of Whatman 3MM paper and dried without ®xing. An autoradiogram was made and cDNA bands of interest from the dried gel were marked through the ®lm. Gel slices were submerged in 100 ml distilled water and boiled for 15 min to elute cDNAs. cDNAs were recovered by ethanol precipitation and were dissolved in 10 ml distilled water. The ampli®ed cDNAs were cloned into the pGEM-T vector using the TA cloning system (pGemT; Promega, Madison, WI, USA). To eliminate false clones, clones were prescreened by dot-blot hybridization with the original ampli®ed cDNA. Sequence analysis was performed in both directions using T7 and SP6 primers with a¯uorescent automated ABI PRISM 377 DNA sequencer (Perkin Elmer). The sequenced cDNAs were analysed via the BLAST program for matches in the GeneBank database and were compared with each other via FASTA analysis. (b) Northern blot analysis of HA61T2 or DNT10 mRNA in 13 representative HCC tissues. HA61T2 is over-expressed in all 13 HCC (T), compared to paired nontumor tissues (N). DNT10 is under-expressed in all HCC with one exception (case no. 33). Twenty mg of nontumor or tumor total RNAs were fractionated on 1% agarose gels containing 2.2% formaldehyde and 50 mM MOPS and transferred to nylon membranes. The blots were individually hybridized with either the HA61T2 or the DNT10 cDNA probe. To con®rm the amounts of mRNA loaded in each lane, the blots were hybridized afterward with glyceraldehyde-3 phosphatase (GAPDH) or 18S ribosomal protein gene cDNA probe. Autoradiographs of Northern hybridizations were scanned using a Personal Densitometer SI (Molecular Dynamics, Sunnyvale, CA, USA). The expression level of each gene was normalized against the level of GAPDH or 18S mRNA and the hybridized signals were then calculated as fold induction from nontumor or HCC tissues, or vice versa prothrombin, or apolipoprotein L-1, apolipoprotein A-1, and LDLC, were down-regulated in HCC tissue in this study, which may result from functional derangement due to malignant transformation of the hepatocytes. The expression of two mitochondrial gene (tRNA and ATPase 6/8), a ribosomal protein (L7), and ®ve novel genes were decreased in the HCC tumor tissues (Table  1B) . The nine novel clones identi®ed (HA61T2, PT18, HG63T1, HG57T1, DNT10, PT8, PT19, ENT25, HA6T4) were subjected to Northern blot analysis to examine their respective mRNA levels after normalization with glyceraldehyde-3 phosphatase (GAPDH) or 18S ribosomal RNA. The nucleotide sequences of those nine genes were completely determined and are shown in Figure 2a . No identical sequences were detected by computer search against GenBank or the EMBL databases. The nine novel clones identi®ed were subjected to Northern blot analysis to examine the expression pro®les of their mRNAs in 40 HCC samples which were grouped by serology into HBV positive or negative, and which were further grouped into high serum (more than 300 ng/ml) or low serum AFP levels. The over-expression of HA61T2 mRNA was more commonly encountered in HCC, irrespective of HBV serology or AFP serum level (P50.001) ( Table 2A) . The expression pro®les of PT18 or HG63T1 were not signi®cantly dierent between HBV-positive and HBVnegative or between high AFP and low AFP tissues. HG57T1 mRNA over-expression was strongly associated with HBV-positive serology and a low serum AFP level (P50.05). The expression of DNT10 signi®cantly decreased in tumor tissues of patients with high AFP levels, irrespective of their HBV serology (P=0.005) ( Table 2B ). The expression of HA6T4 was signi®cantly decreased in tumor tissues of patients with HBV-positive serology and high AFP levels (P=0.038). The expression patterns of PT8 or PT19 did not show any preferential tendency in either group. Northern blot analyses of HA61T2 or DNT10 mRNAs in 13 representative HCC and in their paired nontumor tissues is shown in Figure 2b . Many reported HCCspeci®c genes including AFP (Peng et al., 1993) , glutamine synthetase (Matsuno and Goto, 1992; Laurence et al., 1994) , HIP/PAP (Lasserre et al., 1992; Montalto et al., 1998) , insulin receptor substrate-1-like gene (Nishiyama and Wands, 1992) and CD24 (Huang and Hsu, 1995) are up-regulated in only a certain percentage of HCCs. Particularly, the quantitation of serum AFP has been widely used as a diagnostic marker for HCC. However, elevation of serum AFP in benign hepatic diseases, such as acute or chronic viral hepatitis as well as toxic liver injury, is associated with transient increases in serum AFP. A wide range of overlap in the distribution of serum AFP levels between HCC and chronic liver disease patients were observed mainly in HBsAg-positive patients or in patients with chronic hepatitis C (Chen and Sung, 1979; Bayati et al., 1998) . Thus, complementary biomarker(s) for HCC have been continuously searched for. Among the nine novel genes we isolated, HA61T2 (which seems to be the unidenti®ed KIAA0429 gene product, accession AB007889), was preferentially expressed in HCC tumor tissues, and was irrelevant to either HBV serology or AFP serum level. Thus, this gene may be a useful target for studying hepatocarcinogenesis or as a biomarker of HCC. The size of KIAA0429 mRNA is 5645 bp. However, the size of HA61T2 mRNA was about 500 bp. Thus, HA61T2 seems to be an isoform or an alternatively spliced form of KIAA0429 mRNA. HG57T1 was preferentially expressed in tumor tissues that were serum HBVpositive and had low AFP levels, suggesting that it may serve as a complementary tumor biomarker in HBVpositive patients with normal levels of AFP. The expression of DNT10 (which could be a part of the KIAA0022 gene product, accession XM 002745), decreased in tumor tissues of individuals with high AFP serum levels, irrespective of HBV serology. Thus, the DNT10 gene could be involved in hepatocyte dierentiation because of its reverse relationship with AFP, a dedierentiation marker (Cairo and Lucchini, 1993) . In contrast, the expression of HA6T4 preferentially decreased in tumor tissues of patients that were serum HBV-positive and had high AFP levels. Therefore, it is possible that HA6T4 is involved in HBVassociated hepatocarcinogenesis. Originally, HA6T4 was identi®ed as an up-regulated gene in the tumor of patient B. However, its expression was dominant in noncancerous tissues when measured by Northern analysis. In contrast, the PT18 gene was identi®ed as a down-regulated gene in tumor tissue of patient C, but it was preferentially expressed in tumor tissues of multiple samples. The preferential expression of seven other genes that originated from each patient were in accordance with the results of Northern analysis.
In conclusion, the novel genes as well as the known genes identi®ed in this study should be further analysed and a determination of their functional role(s) should improve our understanding of the molecular mechanism(s) of hepatocarcinogenesis.
